Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 4 Open-market sale Chief Financial Officer sold 3,326 shares at $11.11 ($36,954)
  2. 4 Open-market sale Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,596)
  3. 4 Open-market sale Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,589)
  4. 4 Open-market buy Director bought 8,100 shares at $12.45 ($100,845)
  5. 4 Open-market sale Chief Medical Officer sold 6,580 shares at $14.35 ($94,418)
  6. 4 Open-market sale Co-Chief Executive Officer sold 29,975 shares at an average $14.38 ($430,952)
  7. 4 Open-market sale Chief Legal Officer sold 8,828 shares at $14.58 ($128,669)
  8. 4 Open-market sale Chief Financial Officer sold 10,558 shares at $14.65 ($154,650)
  9. 4 Open-market sale Co-Chief Executive Officer sold 29,933 shares at an average $14.35 ($429,469)
  10. 4 Open-market sale Chief Medical Officer sold 12,039 shares at $14.58 ($175,518)
  11. 4 Planned sale Chief Legal Officer sold 30,000 shares at an average $8.20 ($246,149)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Gift Chief Legal Officer gave 1,000 shares (gift)
  18. 4 Open-market sale Chief Financial Officer sold 10,896 shares at $3.47 ($37,806)
  19. 4 Open-market sale Chief Medical Officer sold 12,425 shares at $3.47 ($43,082)
  20. 4 Open-market sale Chief Legal Officer sold 9,192 shares at $3.48 ($31,954)

Page 3 of 11 · 207 filings